Niva Bupa Health Insurance Company Limited (BOM:544286)
India · Delayed Price · Currency is INR 76.22
-0.68 (-0.88%)
At close: Feb 13, 2026
BOM:544286 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Premiums & Annuity Revenue | 73,350 | 58,399 | 44,179 | 26,628 | 17,525 | 11,509 |
Total Interest & Dividend Income | 6,105 | 4,665 | 2,970 | 1,862 | 1,228 | 863.99 |
Gain (Loss) on Sale of Investments | 92.9 | 92.8 | 111.08 | 49.4 | 262.54 | 60.4 |
Other Revenue | 124.98 | 145.78 | 36.93 | 3,641 | 2,677 | 1,724 |
Total Revenue | 79,673 | 63,302 | 47,297 | 32,180 | 21,693 | 14,157 |
Revenue Growth (YoY) | 26.02% | 33.84% | 46.98% | 48.35% | 53.23% | 35.77% |
Policy Benefits | 70,788 | 55,829 | 41,280 | 14,393 | 10,886 | 6,456 |
Policy Acquisition & Underwriting Costs | - | - | - | 1,908 | 1,204 | 634.81 |
Depreciation & Amortization | 206.93 | 206.93 | 282.25 | - | - | - |
Selling, General & Administrative | 1,894 | 1,894 | 1,745 | 11,842 | 8,598 | 5,454 |
Provision for Bad Debts | - | - | - | 10.25 | 221.71 | 283.45 |
Other Operating Expenses | 228.74 | 13.24 | 28.42 | 3,634 | 2,681 | 1,765 |
Total Operating Expenses | 75,351 | 60,177 | 45,516 | 31,787 | 23,591 | 14,592 |
Operating Income | 4,322 | 3,126 | 1,781 | 393.04 | -1,899 | -435.46 |
Interest Expense | -369.27 | -365.57 | -352.02 | -267.5 | -65.23 | -59.38 |
Currency Exchange Gain (Loss) | - | - | - | -0.14 | -1.27 | -2.54 |
Other Non Operating Income (Expenses) | - | - | - | - | 0.01 | -0 |
EBT Excluding Unusual Items | 3,952 | 2,760 | 1,429 | 125.4 | -1,965 | -497.39 |
Pretax Income | 3,952 | 2,760 | 1,429 | 125.4 | -1,965 | -497.39 |
Income Tax Expense | 1,035 | 731.19 | 365.75 | - | - | - |
Net Income | 2,917 | 2,029 | 1,064 | 125.4 | -1,965 | -497.39 |
Net Income to Common | 2,917 | 2,029 | 1,064 | 125.4 | -1,965 | -497.39 |
Net Income Growth | -3.12% | 90.78% | 748.12% | - | - | - |
Shares Outstanding (Basic) | 1,837 | 1,753 | 1,590 | 1,463 | 1,387 | 1,163 |
Shares Outstanding (Diluted) | 1,851 | 1,782 | 1,631 | 1,503 | 1,389 | 1,163 |
Shares Change (YoY) | 4.20% | 9.22% | 8.55% | 8.20% | 19.40% | 8.75% |
EPS (Basic) | 1.59 | 1.16 | 0.67 | 0.09 | -1.42 | -0.43 |
EPS (Diluted) | 1.57 | 1.14 | 0.65 | 0.08 | -1.42 | -0.43 |
EPS Growth | -7.24% | 75.39% | 712.50% | - | - | - |
Free Cash Flow | 10,408 | 16,438 | 8,240 | 5,547 | 3,090 | 2,287 |
Free Cash Flow Per Share | 5.62 | 9.22 | 5.05 | 3.69 | 2.23 | 1.97 |
Operating Margin | 5.42% | 4.94% | 3.77% | 1.22% | -8.75% | -3.08% |
Profit Margin | 3.66% | 3.21% | 2.25% | 0.39% | -9.06% | -3.51% |
Free Cash Flow Margin | 13.06% | 25.97% | 17.42% | 17.24% | 14.25% | 16.16% |
EBITDA | 4,620 | 3,396 | 2,015 | 485.93 | -1,810 | -214.93 |
EBITDA Margin | 5.80% | 5.37% | 4.26% | 1.51% | -8.34% | -1.52% |
D&A For EBITDA | 298.11 | 270.62 | 233.96 | 92.89 | 88.67 | 220.53 |
EBIT | 4,322 | 3,126 | 1,781 | 393.04 | -1,899 | -435.46 |
EBIT Margin | 5.42% | 4.94% | 3.77% | 1.22% | -8.75% | -3.08% |
Effective Tax Rate | 26.20% | 26.49% | 25.59% | - | - | - |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.